Resources and Information

»Case of the Month

Feb 07 2016

Unusual Side Effect of Topical Glaucoma Medication

Bud O'Leary, OD

Dr. William Marcolini discusses an unusual side effect of a topical glaucoma medication.
read more: Full Members Only

 

»Glaucoma Watch

Jan 28 2016

IOP Asymmetry as Glaucoma Risk Factor

Janet Swartz, EdD

During a recent webinar, Dr. Blair Lonsberry discussed intraocular pressure asymmetry as a significant risk factor for glaucoma.
read more

discuss

 

»Case of the Month

Jan 15 2016

What's Worse Than a Migraine?

Bud O'Leary, OD

Dr. William Marcolini discusses a patient with a migraine, red eyes and increased IOP bilaterally. There is an interesting turn of events in this presentation. Listen carefully to the change in the treatment plan after the patient returns for a second visit, and why pilocarpine and an iritodomy are no longer recommended.
read more: Full Members Only

 

»Webinars

Jan 05 2016

CE Approval for Webinars will be Obtained from Individual States

Janet Swartz, EdD

Beginning in 2016, the NGS will apply to individual states for CE approval for our live webinars rather than to COPE.
read more

discuss

 

»Case of the Month

Dec 28 2015

Detecting Visual Field Progression in Glaucoma

Bud O'Leary, OD

Dr. Danica Marrelli discusses the identification of progression in glaucoma using several case examples.
read more: Full Members Only

 

»Case of the Month

Nov 07 2015

Asymmetry

Bud O'Leary, OD

Dr. Eric Schmidt discusses a glaucoma suspect patient with asymmetrical pressures.
read more: Full Members Only

 

»Case of the Month

Oct 17 2015

Anomalous Optic Nerve

Bud O'Leary, OD

Dr. Jim Thimons discusses whether to treat or watch a 14-year-old patient with an anomalous optic nerve.
read more: Full Members Only

 

»Industry News

Sep 21 2015

CLIA Waivers

Janet Swartz, EdD

At the 2015 National Glaucoma Symposium, Rapid Pathogen Screening (RPS) displayed their AdenoPlus® diagnostic test for Adenoviral conjunctivitis and InflammaDry® rapid screening for dry eye. RPS representatives also discussed CLIA (Clinical Laboratory Improvement Amendments) with the NGS and asked for our assistance informing doctors about the CLIA process.
read more

discuss

 

 

previous